KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2

Related articles

1. Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants

   This article has 13 authors:

   1. Amparo L. Figueroa
   2. Bethany Girard
   3. Darin K Edwards
   4. Arshan Nasir
   5. Kimball Johnson
   6. Steven Hack
   7. Xin Cao
   8. Elizabeth de Windt
   9. Veronica Urdaneta
   10. Frances Priddy
   11. Rituparna Das
   12. David C Montefiori
   13. Spyros Chalkias

2. A conserved region T-cell vaccine for Sarbecoviruses

   This article has 16 authors:

   1. Marta Escarra-Senmarti
   2. Jacqueline Brockhurst
   3. Amanda R Maxwell
   4. Taylor Godwin
   5. Tianle Zhang
   6. Yuzheng Chen
   7. Peter K Um
   8. Ludmila Danilova
   9. Wen-Chi Hsu
   10. Cheng Ting Lin
   11. Tomáš Hanke
   12. William R Bishai
   13. Andrew Pekosz
   14. Cory Brayton
   15. Bette Korber
   16. Maximillian Rosario

3. Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccines

   This article has 33 authors:

   1. Amin Addetia
   2. Alexandra Schäfer
   3. Kaitlin Sprouse
   4. Adian Valdez
   5. Ashley Taylor
   6. Mary-Jane Navarro
   7. Jack T Brown
   8. Elizabeth M. Leaf
   9. Marcos C. Miranda
   10. Alexandra C Walls
   11. Jimin Lee
   12. Nicholas J Catanzaro
   13. Catherine Treichel
   14. Isabelle Willoughby
   15. John Powers
   16. David R Martinez
   17. Blue Vesari
   18. Rashmi Ravichandran
   19. Albert J Seo
   20. Cameron Stewart
   21. Benjamin Merz
   22. Emily Beirne
   23. Samantha Zepeda
   24. Anthony Cook
   25. Laurent Pessaint
   26. Ankur Sharma
   27. Darin Edwards
   28. Kunse Lee
   29. Kelly Smith
   30. Tyler Starr
   31. Ralph Baric
   32. Neil P King
   33. David Veesler